- Research article
- Open Access
Kalrn promoter usage and isoform expression respond to chronic cocaine exposure
BMC Neuroscience volume 12, Article number: 20 (2011)
The long-term effects of cocaine on behavior are accompanied by structural changes in excitatory glutamatergic synapses onto the medium spiny neurons of the striatum. The Kalrn gene encodes several functionally distinct isoforms; these multidomain guanine nucleotide exchange factors (GEFs) contain additional domains known to interact with phosphatidylinositides as well as with a number of different proteins. Through their activation of Rho proteins and their interactions with other proteins, the different Kalirin isoforms affect cytoskeletal organization. Chronic exposure of adult male rodents to cocaine increases levels of Kalirin 7 in the striatum. When exposed chronically to cocaine, mice lacking Kalirin 7, the major adult isoform, fail to show an increase in dendritic spine density in the nucleus accumbens, show diminished place preference for cocaine, and exhibit increased locomotor activity in response to cocaine.
The use of alternate promoters and 3'-terminal exons of the mouse Kalrn gene were investigated using real-time quantitative polymerase chain reaction. While the two most distal full-length Kalrn promoters are used equally in the prefrontal cortex, the more proximal of these promoters accounts for most of the transcripts expressed in the nucleus accumbens. The 3'-terminal exon unique to the Kalirin 7 isoform accounts for a greater percentage of the Kalrn transcripts in prefrontal cortex than in nucleus accumbens. Western blot analyses confirmed these differences. Chronic cocaine treatment increases usage of the promoter encoding the Δ-Kalirin isoforms but does not alter full-length Kalirin promoter usage. Usage of the 3'-terminal exon unique to Kalirin 7 increases following chronic cocaine exposure.
Kalrn promoter and 3'-terminal exon utilization are region-specific. In the nucleus accumbens, cocaine-mediated alterations in promoter usage and 3'-terminal exon usage favor expression of Kalirin 7 and Δ-Kalirin 7. The Δ-isoform, which lacks a Sec14p domain and four of the nine spectrin-like repeats found in full-length Kalirin isoforms, increases spine headsize without increasing dendritic spine numbers. Thus cocaine-mediated changes in alternative splicing of the Kalrn gene may contribute importantly to the behavioral, morphological and biochemical responses observed.
Despite the expression of multiple Rho GDP/GTP exchange factors (GEFs) in the nervous system, the Kalrn gene, which encodes multiple isoforms of Kalirin, plays an essential, non-redundant role. Linkage analyses identified Kalrn as a major risk factor for coronary artery disease and stroke [1–3], as well as for schizophrenia and adult attention-deficit/hyperactivity disorder [4–6]. In addition, Kalirin interacts with many different proteins including deleted in schizophrenia 1 (DISC1), a major risk factor for schizophrenia, the inducible form of nitric oxide synthase (iNOS; NOS2), Huntingtin-associated protein 1 (HAP1) and peptidylglycine α-amidating monooxygenase, an essential enzyme for neuropeptide biosynthesis [7–11]. Chronic cocaine treatment increases levels of Kal7 protein in the mouse and rat striatum . Estrogen treatment of ovariectomized female rats increases Kalirin expression , and Alzheimer's Disease is accompanied by a dramatic loss of Kal7 in the hippocampus . Hippocampal Kalirin mRNA is elevated at 4 h following a kainate-induced seizure and remains elevated for a month .
Kalirin has been implicated in many functions. Kalirin is one of a small number of RhoGEFs localized to the postsynaptic density (PSD) . In the adult brain, Kalirin 7 (Kal7) is the predominant isoform and is almost exclusively localized to the PSD [17, 18]. Overexpression of Kal7 leads to increases in dendritic spine number in cultured hippocampal and cortical pyramidal neurons [19–21]. Conversely, a specific reduction of Kal7 in primary neurons causes a dramatic decrease in spine density [13, 21]. Studies on Kalirin have focused on cortex and hippocampus, where Kal7 has a clear role in spine formation and maintenance.
With many functional domains, the different Kalirin isoforms are capable of integrating inputs from a variety of surface molecules (ephrins, N-cadherin, Trk receptors), phosphatidylinositides, cytoskeletal components, PDZ domain proteins like spinophilin and PSD-95, plus signaling molecules and growth factors [18, 22–25]. Kal7 is also crucial for the expression of normal long-term potentiation in CA1 hippocampal pyramidal neurons .
The rat Kalrn gene encompasses more than 65 exons spanning 600 kb of the rat genome, with at least six promoters and five 3'-terminal exons [26–28]. Alternative splicing yields multiple functionally different isoforms of rat Kalirin. We recently developed a mutant mouse specifically lacking the Kal7 isoform (Kal7KO) ; the 3'-terminal exon that encodes a PDZ binding motif known to interact with PSD-95 and AF-6 was eliminated [18, 25]. Kal7KO mice show decreased anxiety-like behavior, impaired acquisition of a passive avoidance task, and abnormal behavioral and morphological responses to chronic cocaine [12, 17]. A total Kalirin knockout mouse (T-KalKO) mice, in which exons 27-28 in the first GEF domain were replaced by a neomycin resistance gene, was also developed . T-KalKO mice also display a number of neurological phenotypes. Use of these mouse models to clarify the role of Kalirin proteins in synaptic plasticity requires better characterization of the major products of the mouse Kalrn gene.
Given the essential role of Kal7 in multiple cocaine-elicited behaviors as well as the interactions of Kalirin with cyclin dependent kinase 5 (Cdk5) and the NR2B subunit of the NMDA receptor [12, 17, 18, 30], proteins important for these behaviors, we chose to examine more closely the effects of cocaine on the expression of different Kalirin isoforms in the striatum and, more specifically, in the ventral striatum or nucleus accumbens. In order to identify the striatal cell types expressing Kal7, we took advantage of mice expressing GFP under control of the D1-dopamine receptor promoter.
Cocaine treatment of mice
Mice were kept in the University of Connecticut Health Center animal facility on a 12 h light/dark cycle (lights on 7:00 am to 7:00 pm) and handled in accordance with University of Connecticut Health Center Institutional Animal Care and Use Committee guidelines. Adult male C57BL/6 mice (Jackson Laboratories; 2-5 months old) were treated daily with cocaine (20 mg/kg/day, i.p.) or saline for 7 days  and sacrificed 24 h after the final injection. When tested, the mice exhibited the expected locomotor sensitization to chronic cocaine administration (not shown) . Mice expressing green fluorescent protein (GFP) under the control of the D1-dopamine receptor promoter were from the University of Missouri Mutant Mouse Regional Resource Center (Tg(Drd1a-EGFP)X60Gsat/Mmmh). These mice were bred at least seven generations into C57Bl/6 (Jackson Labs) before use.
Quantitative polymerase chain reaction (Q-PCR)
RNA was prepared from freshly dissected tissues with Trizol (Invitrogen) following the manufacturer's instructions, except that the isopropanol precipitation step was lengthened to overnight at -20°C and there were 2 ethanol washes instead of one. The cDNA samples were prepared using Superscript II (Invitrogen) and random primers, or iScript (BioRad) with random primers; a 5 min 65°C step was added to the iScript protocol before chilling and adding the enzyme. While GAPDH and actin samples were unaltered by the choice of random priming or oligo-dT priming, Kalirin transcripts, which are much longer, appeared to be 10-50-fold less abundant compared to GAPDH when using oligo-dT priming instead of random priming. Pairwise statistical comparisons used the t-test for two samples assuming unequal variance and the two-tailed value is reported.
Real-time PCR was performed using an Eppendorf Realplex2 machine and Sybr-Green (BioRad), with the default parameters (95°C 2 min; 95°C 15 sec, 55°C 15 sec, 68°C 20 sec; repeat 40x) except that the 68°C elongation was lengthened to 40 sec. Maximal rates of amplification per cycle were calculated for all primer pairs and all samples in all assays and averaged 1.98 ± 0.06 (SD) for a set of 8 consecutive 96-well assays. Data are calculated with respect to GAPDH for each sample within an assay; since values with respect to GAPDH for each transcript were consistent across assays, data were averaged. Use of actin instead of GAPDH for normalization did not alter the results. Primers are listed in Table 1.
All primer pairs were chosen to keep the melt temperature (Tm) between 58 and 62°C (calculated using http://www.basic.northwestern.edu/biotools/oligocalc.html) and products in the 135 ± 20 nt size range. Primers were designed to delineate the unique 5' end of ΔKalirins (AF229255.1), the spectrin domains common to all forms of Kalirin with nine spectrin-like repeats (U88157.1), and sequences unique to the 3' ends of Kal7 (AF230644.1), Kal8 (U88157.1), Kal9 (AF232668.1), and Kal12 (NM_032062.2); rat sequences were used to identify the corresponding mouse sequences, which all appear as Ensembl sequences at http://www.ensembl.org/Mus_musculus/Info/. Additional primer pairs identifying transcripts which extend beyond a unique end (e.g. Exon 33 to Exon 34, Exon 38-39, Exon 51-52) instead of terminating in a specific 3' end, corroborated the major findings (not shown).
Putative mouse Kalrn mRNA initiation exons A, B, C and D were identified by homology to the rat and human Kalrn initiation exons [27, 28], as described here. Mouse Kalrn exons A, B, and C were identified by comparing the known rat sequences (A: Genbank U88157.1; B: U88156.1; C: AF230644.1) with the mouse genome (July 2007 [NCBI37/mm9]) at http://genome.ucsc.edu/cgi-bin/. The putative mouse Kalrn D initiation exon sequence was from XM_001001454.1, and the putative mouse ΔKalrn initiation exon sequence was from ENSMUST00000114949. The A, B, and C sequences all fit the current Ensembl sequences, and C is also a Refseq entry: NM_177357.
Adult male Drd1a-GFP mice were anesthetized with ketamine/xylazine and perfused transcardially with saline followed by 4% paraformaldehyde as described . Brains from two mice were postfixed in 4% paraformaldehyde and then incubated in 25% sucrose in phosphate buffered saline containing 0.02% NaN3. Coronal sections (12 μm) through the striatum and nucleus accumbens were collected on slides and incubated with rat monoclonal antibody to GFP (Nacalai USA, Elkton MD) and affinity-purified rabbit polyclonal antibody to the C-terminus of Kal7 [17, 18]. Anatomical boundaries were determined as in our previous studies using standard atlases [31, 32]. Confocal images were acquired on a Zeiss LSM 510 microscope as described [13, 21]. Neurons expressing GFP and/or Kal7 were identified using MetaMorph; three sections, each of which contained ~40 neurons, were analyzed from each animal for each brain region. Since the minimum distance between sections analyzed using the same antiserum was 84 μm, the same neuron was not counted twice.
Subcellular fractionation and Western blot analysis
Adult male mouse nucleus accumbens, dorsal striatum and cortical punches were sonicated and boiled in 1% SDS, 50 mM Tris [pH 7.4], 5 mM EDTA, 50 mM NaF, 2 mM sodium orthovanadate, 1 mM PMSF and protease inhibitor cocktail . For subcellular fractionation studies, whole striatum was homogenized, fractionated by differential centrifugation followed by sucrose gradient centrifugation and extraction with TX-100, and subjected to Western blot analysis. Where indicated, blots were quantified using Gene Tools (Syngene, Frederick, MD) [12, 17, 33]. Gels were loaded with equal protein using a Bicinchoninic Acid Assay and bovine serum albumin standard to determine protein concentrations (Pierce, Rockford, IL). Commercially available mouse monoclonal antibodies were used: βIII tubulin (TUJ1; Covance), NR2B (clone N59/20; NeuroMab), Cdk5 (Santa Cruz Biotechnology) and Rac1 (Transduction Labs; also 23A8, Millipore).
Kal7 is expressed in the major neuronal cell types in nucleus accumbens and dorsal striatum
Understanding the role Kal7 plays in the effects of cocaine on locomotor activity and place preference requires knowing the striatal cell types in which it is expressed. Mice expressing GFP under the control of the D1 dopamine receptor (Drd1a-GFP mice) were used to investigate the cellular specificity of Kalirin expression in the dorsal striatum and nucleus accumbens (Figure 1). In both regions, more than half of the neurons express GFP, identifying them as D1 receptor positive medium spiny neurons; this ratio is consistent with published studies [34, 35]. Over 90% of the D1 receptor neurons express Kal7. About one-third of the neurons in both regions express Kal7 but do not express GFP. D1 receptor negative neurons that are similar in size to the D1 receptor positive neurons represent medium spiny neurons expressing the D2 dopamine receptor [34, 35]. The small population of very large neurons expressing high levels of Kal7 are aspiny cholinergic interneurons (Figure 1D-F) . Kal7 could play a role at excitatory synapses onto each of these different neuronal cell types.
Usage of promoters encoding full-length mouse Kalrn is region-specific
With the generation of mice lacking the 3'-terminal exon unique to Kal7 and ΔKal7 (Kal7KO mice)  and the distinctly different response of Kal7KO mice to chronic cocaine exposure , a detailed analysis of Kalrn promoter usage and isoform expression in Mus musculus was undertaken (Figure 2). The genes encoding rat and human Kalrn are complex, with multiple initiation exons and multiple 3'-terminal exons responsible for the tissue-specific production of transcripts encoding functionally distinct proteins [26–28]. The gene encoding mouse Kalrn is similarly large, extending over 600 kb (Figure 2). Expression of full-length isoforms of Kalrn, in which a Sec14p domain and nine spectrin-like repeats precede the first GEF domain, is governed by four promoters and their alternative initiation exons (B, C, A, and D) located 1.4 to 180 kb upstream of exon 2 [27, 28] (Figure 2). The alternative initiation exons, which are separated by large introns, encode unique N-termini that are five to 38 amino acids long. Exons 2 to 5 (35 kb) encode the common Sec14p-like domain while exons 5 through 22 (150 kb) encode the nine spectrin-like repeats. Exons 24 through 32 encode the first GEF domain. The 3'-terminal exon unique to Kal7 and ΔKal7 is flanked by two large introns while the exons encoding the second GEF domain (exons 39-47), which is present in Kal9 and Kal12, and the Ser/Thr kinase domain (exons 58-60), which is unique to Kal12, are densely clustered (Figure 2).
Full-length Kalirin promoter usage was assessed by real-time Q-PCR; forward primers located in each initiation exon were paired with a common reverse primer located in exon 3 (Figure 3A). In addition to nucleus accumbens, RNA from prefrontal cortex and hippocampus was analyzed to look for region-specific promoter usage. Although PCR products of the expected size were detected for all four putative full-length promoters, Kalrn promoters B and C accounted for over 95% of the full-length Kalirin transcripts in the adult mouse brain (Figure 3B); usage of promoters A and D was detectable in all three brain regions, but was much less common. The promoter usage patterns for hippocampus and nucleus accumbens were similar to each other, but differed from the pattern observed in the prefrontal cortex. Full-length Kalrn promoters B and C were used equally in the prefrontal cortex, while promoter C was the major promoter in the hippocampus and nucleus accumbens.
Usage of ΔKalrn promoter and alternate 3'-terminal exons is region-specific
In the adult rat brain, usage of a promoter located in the intron that separates exons 10 and 11 yields the Δ-isoforms of Kalirin (Figures 2 and 4A). These isoforms lack the Sec14p domain and the first four spectrin-like repeats of full-length Kalirin. In rat cortical and hippocampal neurons, expression of exogenous Kal7 causes the formation of new dendritic spines. In contrast, expression of ΔKal7 increases spine size, but does not increase spine number .
Expression of transcripts encoding full-length vs. Δ-isoforms of Kalirin in mouse prefrontal cortex and nucleus accumbens was compared using Q-PCR with the indicated primers (Figure 4A); these regions were analyzed because both play essential roles in the response to cocaine and their patterns of promoter usage differed. Transcripts encoding the Δ-isoforms of Kalirin were more prevalent in prefrontal cortex than in nucleus accumbens (Figure 4B). Based on using primer pairs that spanned exons 10 and 11 (Figure 4A), transcripts encoding full-length isoforms of Kalirin were expressed at similar levels in these two brain regions.
Primers specific to the 3'-terminal exons unique to the different Kalrn isoforms (Figures 2, 4A) were used to look for differences between prefrontal cortex and nucleus accumbens (Figure 4C). Q-PCR analysis revealed much higher levels of transcripts encoding the Kal7-specific exon in prefrontal cortex than in nucleus accumbens. These transcripts could encode full-length Kal7 or ΔKal7. The Kal7-specific exon encodes a PDZ-binding domain known to interact with PSD-95 and spinophilin . Transcripts encoding Kal8, Kal9 and Kal12 were detected at much lower levels in both tissues, with no tissue-specific differences. The isoforms of Kalirin that include both GEF1 and GEF2 (Kal9, Kal12) account for a larger fraction of the Kalirin transcripts in the nucleus accumbens than in the prefrontal cortex.
Kal7 is the major Kalirin protein in the dorsal striatum and nucleus accumbens
Western blot analysis was used to compare expression of the major Kalirin isoforms in adult mouse cortex, where its role in spine formation has been studied [17, 29, 30, 32, 37–39] to dorsal striatum and nucleus accumbens (ventral striatum), the brain regions affected most dramatically by cocaine [12, 35, 40–47]. Using an antibody specific for spectrin repeats 4-7 of Kalirin (Kal-Spec Ab), cross-reactive proteins the size of Kal12 (337 kDa), Kal9 (271 kDa), Kal7 (190 kDa) and ΔKal7 (117 kDa) were detected (Figure 5, top left). Higher levels of Kal12, Kal7 and ΔKal7 were present in cortex than in dorsal or ventral striatum. In contrast, levels of βIII tubulin were similar in all three brain regions.
To confirm the identity of the bands identified as Kal7 and ΔKal7, antiserum specific to the unique COOH-terminus of Kal7 was used (Figure 5, top right). Levels of both Kal7 and ΔKal7 were higher in cortex than in striatum or nucleus accumbens, with a clear signal for ΔKal7 detected only in cortex. As observed in the rat [26, 28], levels of ΔKal7 protein were significantly lower than predicted based on utilization of the ΔKalrn promoter (Figure 4B).
Kalirin function is altered when Thr1590 is phosphorylated by cyclin dependent kinase 5 (Cdk5), and levels of both Cdk5 and NR2B are decreased in PSDs prepared from Kal7KO animals [17, 30]. We therefore compared levels of NR2B and Cdk5 in these three brain regions (Figure 5); similar levels of both proteins were detected in all three regions. We also examined levels of Rac1, one of the major substrates of Kal7, in the same brain regions; again, no dramatic differences were observed (Figure 5).
Striatal PSDs are enriched in Kal7
In the rat, mouse and gerbil cortex and hippocampus, subcellular fractionation reveals a significant enrichment of Kal7 at the PSD [3, 17, 18]. We prepared PSDs from mouse striatum to examine the distribution of the different Kalirin isoforms in this brain region (Figure 6). The distributions of BiP, an ER resident chaperone, and the NR2B subunit of the NMDA receptor, were used to verify the success of the fractionation scheme. As expected, BiP was enriched in the P3 fraction, which contains ER, Golgi and other intracellular membranous compartments, and NR2B was enriched in the PSD fraction. Cytosol was enriched in Kal12 and Kal9 and was devoid of Kal7. Kal7 was enriched in the PSD fraction, which also contained detectable amounts of Kal12 and Kal9, but no detectable ΔKal7.
Since Rac1 is one of the key substrates of Kal7, its distribution was also monitored (Figure 6). Although attached to the membrane by a geranylgeranyl tail, most of the Rac1 remained associated with the TX-100 washed PSD fraction. Very little Rac1 was removed by the TX-100 extraction step, leaving the TX-100 soluble fraction (TxS) depleted of Rac1.
We previously quantified the amount of Kal7 in purified PSDs prepared from adult mouse hippocampus and cortex . Using purified ΔKal7 as a standard, the same measurement was made on purified striatal PSDs (Figure 7). The levels of Kal7 in striatal-PSDs were about half of those observed in the cortex and hippocampus. A difference of this magnitude is consistent with the results of in situ hybridization studies of Kalirin expression in these tissues .
Chronic cocaine treatment alters promoter and 3'-terminal exon expression
Adult male mice were treated with cocaine (20 mg/kg) for 7 days and nucleus accumbens was then harvested for preparation of RNA (Figure 8). Utilization of full-length Kalrn promoters A, B, C and D was first evaluated; following injection of saline or cocaine, Kalrn promoter C accounted for most of the full-length transcripts produced (Figure 8A). Usage of the ΔKalrn promoter was next compared to the total level of full-length Kalrn transcript (Figure 8B). Chronic cocaine treatment increased usage of the ΔKalrn promoter without altering expression of full-length transcripts (Figure 8B).
The effect of chronic cocaine on usage of different Kalrn 3'-terminal exons was next evaluated (Figure 8C). In the nucleus accumbens, the number of Kalirin transcripts generated using the Kal7-specific 3'-terminal exon increased following chronic treatment with cocaine. No significant change was seen in the level of transcripts encoding Kal8 or Kal12 and levels of Kal9 fell slightly (Figure 8C).
Effect of chronic cocaine on expression of Kalirin isoforms in striatal neurons
In order to evaluate changes in Kalirin isoform expression, PSDs were prepared from the striata of mice treated chronically with saline or cocaine (Figure 9A). Analysis of equal amounts of input (S1) and PSD protein revealed increased levels of Kal7 protein in both samples. DARPP32, a soluble protein enriched in striatal neurons, was excluded from the purified PSDs, attesting to their purity. Small amounts of Kal9 and Kal12 could be detected in the purified PSDs, but Kal12 was barely detectable in the input samples. The identification of the Kal7 band was verified with the Kal7-specific antibody (Figure 9B).
Many of the effects of cocaine involve the nucleus accumbens, or ventral striatum. Since preparation of purified PSDs from this relatively small region would require the use of multiple animals, we evaluated the effects of chronic cocaine on total lysates. Western blot analyses of nucleus accumbens extracts with the Kal-spectrin antibody revealed a 60% increase in Kal7 protein levels (Figure 9C); Kal9 levels were unchanged following cocaine treatment and Kal12 levels were too low for accurate quantification.
Discussion and Conclusions
Tissue-specific use of full-length Kalrn Promoters
The pattern of Kalrn promoter usage differs in NAc and prefrontal cortex; the C-promoter accounts for most of the full-length transcripts in the NAc while the B- and C-promoters contribute equally in the prefrontal cortex. The rat Kalrn A promoter was the first one identified and came from a cDNA library prepared from P21 rat hippocampus and cortex following electroconvulsive shock . Subsequent studies demonstrated that the Kalrn A promoter is a minor contributor in the adult rat, mouse and human tissues examined [27, 28]. The Kalrn D promoter is also a minor contributor in adult brain, but is the dominant Kalrn promoter in the pituitary (not shown). The Duet promoter, which produces transcripts that lack all of Kal7, is rarely used in the rat or human brain  and was not examined in this study. Interestingly, the intron sizes shown for mouse in Figure 1 are virtually identical to those reported for rat and human .
The N-terminal sequences encoded by the mouse and rat Kalrn B promoters are identical, as are the N-terminal sequences encoded by the mouse and rat Kalrn C promoters. Most of the full-length Kalirin isoforms in the NAc will begin with the more hydrophobic N-terminal sequence encoded by the Kalrn C promoter . The functional consequences of this difference have not yet been explored, but the proximity of this short sequence to the Sec14p domain, which is known to bind phosphatidylinositol-3-phosphate , suggests that future studies might identify an important role for the N-terminus of Kalirin.
Cocaine regulation of ΔKalrn promoter and Kal7 3'-terminal exon usage
Chronic cocaine treatment increased the prevalence of transcripts generated using the ΔKalrn promoter (Figure 8B). Neither the level of full-length Kalirin transcripts nor usage of the Kalrn B and C promoters (Figure 8A) was altered by this treatment. Chronic cocaine treatment is known to increase expression of several transcription factors, including CREB, ΔFosB, MEF2 and Sp1, in the NAc [45, 47, 49–51]. Our own analyses demonstrated an increase in transcripts encoding CREB, MEF2 and Sp1 in the NAc of mice treated with this particular regimen of cocaine .
We therefore examined 1 kilobase of genomic sequence immediately upstream of the ΔKal, Kal B and Kal C transcriptional start sites for the presence of consensus binding sites for these four transcription factors (Figure 10). Consensus sites for CREB, ΔFosB and MEF2A were not found in these regions. A consensus Sp1 site (GGGCGG) was identified close to the ΔKalrn transcriptional start site ; this site is perfectly conserved in mouse and rat. Consensus Sp1 sites, or close matches, were identified in the Kalrn B, Kalrn C and Kalrn A promoters, but are over 300 nucleotides from the transcriptional start site; none occur in the Kalrn D promoter (Figure 10). Because they are GC-rich, Sp1 sites are strongly affected by chromatin methylation . Interfering pharmacologically with Sp1 function (e.g. with mithramycin) is known to block psychostimulant sensitization  and Sp1 binding to the proximal promoters of the mu opioid receptor has been clearly demonstrated .
Chronic treatment with cocaine also increased the level of transcripts that include the Kal7-specific 3'-terminal exon (Figure 8). Inclusion of this 3'-terminal exon results in the production of transcripts encoding Kal7 or ΔKal7 and precludes the production of Kal8, Kal9 or Kal12. Since chronic cocaine treatment had no effect on the level of full-length Kalirin transcripts (Figure 8B), an increase in the splicing events that include the Kal7-specific 3'-terminal exon would be associated with diminished usage of other 3'-terminal exons. While usage of the Kal8- and Kal12-specific exons was unaltered, usage of the Kal9-specific 3'-terminal exon declined slightly.
The effects of cocaine treatment on alternative splicing have received little attention. However, acute exposure to cocaine is known to alter splicing of transcripts encoded by the rat BDNF gene . BDNF, acting through its TrkB receptor, plays an important role in the behavioral response to cocaine and enhances responsiveness to glutamate [57–59]. Cocaine- and activity-regulated alternative splicing of the Homer family of scaffolding proteins also affects synaptic signaling [43, 60]. For Kalrn, splicing events that lead to the inclusion of different 3'-terminal exons produce proteins with distinctly different functions. Since the GEF2 region of Kalirin can be activated upon binding Gαq , leading to activation of RhoA, even a slight shift in the ratio of isoforms with both GEF domains vs GEF1 alone should be of significance. Cocaine-induced alternative splicing of Kalrn transcripts may be important in the biochemical and/or behavioral response to cocaine.
Kalirin expression in the striatum
The primary site of action of cocaine is the nucleus accumbens and the rest of the striatum [47, 62, 63]. Kal7 is expressed in almost all of the neurons in the dorsal striatum and nucleus accumbens that express the D1 receptor, but its expression is not limited to this population of neurons. Since medium spiny neurons expressing the D1 dopamine receptor and the D2 dopamine receptor receive different excitatory glutamatergic inputs and are part of very different functional pathways , examining the role of Kal7 in the effects of cocaine on both neuronal populations will be important. Whether expression of high levels of Kal7 in giant aspiny striatal cholinergic interneurons [36, 63] plays an important role in the actions of cocaine will require additional studies.
Based on Q-PCR analysis, expression of Kalirin in the NAc is lower than in hippocampus or prefrontal cortex. Consistent with a role for Kalirin in spine formation, dendritic spine density on NAc medium spiny neurons is lower than on hippocampal CA1 pyramidal neurons [12, 24]. In addition, PSDs purified from mouse striatum contained substantially lower levels of Kal7 than PSDs from cortex or hippocampus (Figure 7A). While the typical cortical or hippocampal PSD is estimated to have 9-12 molecules of Kal7, the typical striatal PSD would have only five.
Western blot analysis revealed an increase in levels of Kal7 in lysates of NAc and in purified striatal PSDs following chronic cocaine treatment (Figure 9). Many factors contribute to steady state protein levels, but the cocaine-stimulated increase in usage of the Kal7-specific 3'-terminal exon, coupled with maintained usage of the full-length Kalrn C promoter could account for the observed change. No cocaine-mediated alteration in Kal9 protein levels was observed (Figure 9B), despite a decrease in usage of the Kal9 specific 3'-terminal exon (Figure 8C). While ΔKal7 is detectable in mouse cortex, it is far less prevalent than predicted by promoter usage. The presence of four start codons followed by in-frame stop codons in the 5'-untranslated region of mouse ΔKal7 may limit successful translation , and increased turnover ΔKal7, a soluble, cytosolic protein, may contribute to this discrepancy.
A transient, cocaine-mediated change in levels of Kal7 vs. ΔKal7 would be expected to have functional significance. While expression of exogenous Kal7 increases spine density in cortical and hippocampal pyramidal neurons and even in interneurons [13, 21, 24], expression of exogenous ΔKal7 does not. Expression of ΔKal7 does increase spine head size  and the cocaine-mediated increase in ΔKalrn promoter usage may contribute to the increase in spine width known to occur following cocaine administration [12, 24]. Kal7 binding to its partners might be disrupted by ΔKal7, much as Homer-1a disrupts the clusters of proteins formed with the longer constitutive splice variants of the Homer family .
Initial studies on Kal7KO mice confirmed a role for Kal7/ΔKal7 in nervous system function [12, 17]. A slight decrease in linear spine density on CA1 hippocampal pyramidal neurons is accompanied by a decrease in spontaneous EPSP frequency and deficient hippocampal LTP . In contrast, spine density is normal in the Kal7KO NAc under basal conditions . Although chronic administration of cocaine increases spine density on the medium spiny neurons in the NAc [35, 42, 65], this response is absent in Kal7KO mice . The behavioral responses of Kal7KO mice to chronic cocaine are also altered . Levels of both Cdk5 and NR2B, which play essential roles in the structural and behavioral responses to cocaine [17, 30, 41, 66–69], are diminished in PSDs prepared from the cortices of Kal7KO mice. A similar relationship between Kal7 and Cdk5 and NR2B in the NAc may contribute to the behavioral deficits observed.
Although the Na+-dependent plasma membrane dopamine transporter is the immediate target of cocaine, the effects of chronic exposure to cocaine are complex, wide-spread and long-lasting. Since no effective treatment is available, it is essential to develop a better understanding of the molecular, cellular and system-wide changes that lead to addiction. Structural changes at many of the synapses involved in addiction are thought to underlie these long-lived changes. Since dendritic spine morphology is largely controlled by the actin cytoskeleton, attention has turned to the pathways through which cocaine could alter the cytoskeleton. Small GTP binding proteins of the Rho family play an important role in this process and are activated by RhoGEFs and inactivated by Rho GTPase Activating Proteins. There are ~60 RhoGEFs in the human genome, and about a dozen are found in significant amounts at the PSD . We have focused on one of these RhoGEFs, Kalirin, because it is essential for normal synaptic function and mice engineered to lack its major adult isoform exhibit altered responses to cocaine [12, 17].
Wang L, Hauser ER, Shah SH, Pericak-Vance MA, Goldschmidt-Clermont PJ, Vance JM: Peakwide mapping on chromosome 3q13 identifies the Kalirin gene as a novel candidate gene for coronary artery disease. Am J Hum Genet. 2007, 80: 650-663. 10.1086/512981.
Krug T, Manso H, Gouveia L, Sobral J, Xavier JM, Oliveira SA: Kalirin: a novel genetic risk factor for ischemic stroke. Hum Genet. 2010, 127: 513-523. 10.1007/s00439-010-0790-y.
Beresewicz M, Kowalczyk JE, Jablocka B: Kalirin-7, a protein enriched in postsynaptic density, is involved in ischemic signal transduction. Neurochem Res. 2008, 33: 1789-1794. 10.1007/s11064-008-9631-y.
Hill JJ, Hashimoto T, Lewis DA: Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol Psychiatry. 2006, 11: 557-566. 10.1038/sj.mp.4001792.
Kushima I, Nakamura Y, Aleksic B, Ikeda M, Ito Y, Ozaki N: Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility. Schizo Bull. 2010,PMID: 21041834.
Lesch KP, Timmesfeld N, Renner TJ, Halperin R, Stephan DA, Jacob C: Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm. 2008, 115: 1573-1585. 10.1007/s00702-008-0119-3.
Ratovitski EA, Alam MR, Quick RA, McMillan A, Bao C, Hand TA, Johnson RC, Mains RE, Eipper BA, Lowenstein CJ: Kalirin inhibition of inducible nitric oxide synthase. J Biol Chem. 1999, 274: 993-999. 10.1074/jbc.274.2.993.
Colomer V, Engelender S, Sharp AH, Duan K, Cooper JK, Lanahan A, Lyford G, Worley P, Ross CA: Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain. Hum Mol Genet. 1997, 6: 1519-1525. 10.1093/hmg/6.9.1519.
Hayashi-Takagi A, Takaki M, Graziane N, Seshadri S, Penzes P, Sawa A: Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci. 2010, 13: 327-332. 10.1038/nn.2487.
Youn HS, Ji I, Ji H, Markesbery WR, Ji TH: Under-expression of Kalirin-7 Increases iNOS activity in cultured cells and correlates to elevated iNOS activity in Alzheimer's disease hippocampus. J Alzheimers Disease. 2007, 12: 271-281.
Alam MR, Caldwell BD, Johnson RC, Darlington DN, Mains RE, Eipper BA: Novel proteins that interact with the COOH-terminal cytosolic routing determinants of an integral membrane peptide-processing enzyme. J Biol Chem. 1996, 271: 28636-28640. 10.1074/jbc.271.45.28636.
Kiraly DD, Ma XM, Mazzone CM, Xin X, Mains RE: Behavioral and Morphological Responses to Cocaine Require Kalirin7. Biol Psychiatry. 2010, 68: 249-255. 10.1016/j.biopsych.2010.03.024.
Ma XM, Huang JP, Kim EJ, Zhu Q, Kuchel GA, Mains RE, Eipper BA: Kalirin-7, an Important Component of Excitatory Synapses, is Regulated by Estradiol in Hippocampal Neurons. Hippocampus. 2010
Youn HS, Jeoung MK, Koo YB, Ji H, Markesbery WR, Ji I, Ji TH: Kalirin is under-expressed in Alzheimer's Disease hippocampus. J Alzheimers Disease. 2007, 11: 385-397.
Sharma AK, Searfoss GH, Reams RY, Jordan WH, Snyder PW, Ryan TP: Kainic Acid-induced F-344 Rat model of Mesial Temporal Lobe Epilepsy: Gene Expression and Canonical Pathways. Toxicol Pathol. 2009, 37: 776-789. 10.1177/0192623309344202.
Kiraly DD, Eipper-Mains JE, Mains RE, Eipper BA: Synaptic Plasticity, a Symphony in GEF. ACS Chem Neurosci. 2010, 1: 348-365. 10.1021/cn100012x.
Ma XM, Kiraly DD, Gaier ED, Wang Y, Kim EJ, Levine ES, Eipper BA, Mains RE: Kalirin-7 Is Required for Synaptic Structure and Function. J Neurosci. 2008, 28: 12368-12382. 10.1523/JNEUROSCI.4269-08.2008.
Penzes P, Johnson RC, Sattler R, Zhang X, Huganir RL, Kambampati V, Mains RE, Eipper BA: The neuronal Rho-GEF Kalirin-7 interacts with PDZ domain-containing proteins and regulates dendritic morphogenesis. Neuron. 2001, 29: 229-242. 10.1016/S0896-6273(01)00193-3.
Ma XM, Huang JP, Wang Y, Eipper BA, Mains RE: Kalirin, a multifunctional Rho GEF, is necessary for maintenance of hippocampal pyramidal neuron dendrites and dendritic spines. J Neurosci. 2003, 23: 10593-10603.
Xie Z, Srivastava DP, Photowala H, Kai L, Surmeier J, Penzes P: Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines. Neuron. 2007, 56: 640-656. 10.1016/j.neuron.2007.10.005.
Ma XM, Wang Y, Ferraro F, Mains RE, Eipper BA: Kalirin-7 Is an Essential Component of both Shaft and Spine Excitatory Synapses in Hippocampal Interneurons. J Neurosci. 2008, 28: 711-724. 10.1523/JNEUROSCI.5283-07.2008.
Penzes P, Beeser A, Chernoff J, Schiller MR, Eipper BA, Mains RE, Huganir RL: Rapid induction of dendritic spine morphogenesis by trans-synaptic ephrinB-EphB receptor activation of the Rho-GEF kalirin. Neuron. 2003, 37: 263-274. 10.1016/S0896-6273(02)01168-6.
Chakrabarti K, Lin R, Schiller NI, Wang Y, Koubi D, Fan YX, Rudbin BB, Johnson GR, Schiller MR: Critical role for Kalirin in nerve growth factor signaling through TrkA. Mol Cell Biol. 2005, 25: 5106-5118. 10.1128/MCB.25.12.5106-5118.2005.
Schiller MR, Ferraro F, Wang Y, Ma XM, McPherson CE, Sobota JA, Schiller NI, Mains RE, Eipper BA: Autonomous functions for the Sec14p/spectrin-repeat region of Kalirin. Exp Cell Res. 2008, 314: 2674-2691. 10.1016/j.yexcr.2008.05.011.
Xie Z, Photowala H, Cahill ME, Srivastava DP, Woolfrey KM, Shum CY, Huganir RL, Penzes P: Coordination of synaptic adhesion with dendritic spine remodeling by AF-6 and Kalirin-7. J Neurosci. 2008, 28: 6079-6091. 10.1523/JNEUROSCI.1170-08.2008.
Johnson RC, Penzes P, Eipper BA, Mains RE: Isoforms of kalirin, a neuronal Dbl family member, generated through use of different 5'- and 3'-ends along with an internal translational initiation site. J Biol Chem. 2000, 275: 19324-19333. 10.1074/jbc.M000676200.
McPherson CE, Eipper BA, Mains RE: Genomic organization and differential expression of Kalirin isoforms. Gene. 2002, 284: 41-51. 10.1016/S0378-1119(02)00386-4.
McPherson CE, Eipper BA, Mains RE: Kalirin expression is regulated by multiple promoters. J Mol Neurosci. 2004, 22: 51-62. 10.1385/JMN:22:1-2:51.
Cahill ME, Xie Z, Day M, Photowala H, Sweatt JD, Surmeier DJ, Penzes P: Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc Natl Acad Sci USA. 2010, 106: 13058-13063. 10.1073/pnas.0904636106.
Xin X, Wang Y, Ma XM, Rompolas P, Keutmann HT, Mains RE, Eipper BA: Regulation of kalirin by cdk5. J Cell Sci. 2008, 121: 2601-2611. 10.1242/jcs.016089.
Paxinos G, Franklin KB: The Mouse Brain Stereotaxic Coordinates. 2000, Academic Press, 2
Ma XM, Johnson RC, Mains RE, Eipper BA: Expression of Kalirin, a Neuronal GDP/GTP Exchange Factor of the Trio Family, in the Central Nervous System of the Adult Rat. J Comp Neurol. 2001, 429: 388-402. 10.1002/1096-9861(20010115)429:3<388::AID-CNE3>3.0.CO;2-I.
Xin X, Rabiner CA, Mains RE, Eipper BA: Kalirin12 interacts with dynamin. BMC Neurosci. 2009, 10: 61-10.1186/1471-2202-10-61.
Bateup HS, Santini E, Shen W, Birnbaum S, Nestler EJ, Greengard P: Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc Natl Acad Sci USA. 2010, 107: 14845-14850. 10.1073/pnas.1009874107.
Lee KW, Kim Y, Kim AM, Helmin K, Nairn AC, Greengard P: Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci USA. 2006, 103: 3399-3404. 10.1073/pnas.0511244103.
Sizemore RJ, Reynolds JNJ, Oorschot DE: Number and type of synapses on the distal dendrite of a rat striatal cholinergic interneuron: a quantitative, ultrastructural study. J Anat. 2010, 217: 223-235. 10.1111/j.1469-7580.2010.01264.x.
Penzes P, Johnson RC, Alam MR, Kambampati V, Mains RE, Eipper BA: An Isoform of Kalirin, a Brain-Specific GDP/GTP Exchange Factor, Is Enriched in the Postsynaptic Density Fraction. J Biol Chem. 2000, 275: 6395-6403. 10.1074/jbc.275.9.6395.
Penzes P, Jones KA: Dendritic spine dynamics--a key role for kalirin-7. Trends Neurosci. 2008, 31: 419-427. 10.1016/j.tins.2008.06.001.
Xie Z, Cahill ME, Penzes P: Kalirin loss results in cortical morphological alterations. Mol Cell Neurosci. 2010, 43: 81-89. 10.1016/j.mcn.2009.09.006.
Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, Greengard P: Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature. 2001, 410: 376-380. 10.1038/35066591.
Norrholm SD, Bibb JA, Nestler EJ, Ouimet CC, Taylor JR, Greengard P: Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience. 2003, 116: 19-22. 10.1016/S0306-4522(02)00560-2.
Robinson TE, Gorny G, Mitton E, Kolb B: Cocaine Self-Administration Alters the Morphology of Dendrites and Dendritic Spines in the Nucleus Accumbens and Neocortex. Synapse. 2001, 39: 257-266. 10.1002/1098-2396(20010301)39:3<257::AID-SYN1007>3.0.CO;2-1.
Szumlinski KK, Dehoff MH, Kang SH, Frys KA, Worley PF, Kalivas PW: Homer proteins regulate sensitivity to cocaine. Neuron. 2004, 43: 401-413. 10.1016/j.neuron.2004.07.019.
Yee J, Famous KR, Hopkins TJ, McMullen MC, Pierce RC, Schmidt HD: Muscarinic acetylcholine receptors in the nucleus accumbens core and shell contribute to cocaine priming-induced reinstatement of drug seeking. Eur J Pharmacol. 2010,PMID: 21034738.
Carlezon WA, Thome J, Olson VG, Lane-Ladd SB, DUman RS, Nestler EJ, Neve RL, Nestler EJ: Regulation of cocaine reward by CREB. Science. 1988, 282: 2272-2275. 10.1126/science.282.5397.2272.
Nestler EJ: Cellular responses to chronic treatment with drugs of abuse. Crit Rev Neurobiol. 1993, 7: 23-39.
Pulipparacharuvil S, Renthal W, Hale CF, Greengard P, Nairn AC, Nestler EJ, Cowan CW: Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron. 2008, 59: 621-633. 10.1016/j.neuron.2008.06.020.
McPherson CE, Eipper BA, Mains RE: Kalirin expression is regulated by multiple promoters. J Mol Neurosci. 2004, 22: 51-62. 10.1385/JMN:22:1-2:51.
Chen J, Nye HE, Kelz MB, Nakabeppu Y, Hope BT, Nestler EJ: Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol Pharmacol. 1995, 48: 880-889.
Imam SZ, Duhart HM, Skinner JT, Ali SF: Cocaine induces a differential dose-dependent alteration in the expression profile of immediate early genes, transcription factors, and caspases in PC12 cells. Ann N Y Acad Sci. 2005, 1053: 482-490. 10.1196/annals.1344.042.
Hagiwara H, Iyo M, Hashimoto K: Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine. Brain Res. 2009, 1301: 189-196. 10.1016/j.brainres.2009.09.010.
Eipper-Mains JE, Kiraly DD, Horowitz MJ, McManus C, Eipper BA, Mains RE, Graveley BR: Cocaine and the mouse brain: Exploring the transcriptome with mRNA-Seq. Soc Neurosci Abst. 2009,254.22.
Kovarik A, Lu PJ, Peat N, Morris J, Taylor-Papadimitriou J: Two GC boxes (Sp1 sites) are involved in regulation of the activity of the epithelium-specific MUC1 promoter. J Biol Chem. 1996, 271: 18140-18147. 10.1074/jbc.271.30.18140.
Hwang CK, Kim CS, Kim do K, Law PY, Wei LN, Loh HH: Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells. Mol Pharmacol. 2010, 78: 58-68. 10.1124/mol.110.064311.
Li H, Liu H, Wang Z, Liu X, McNutt MA, Li G: The role of transcription factors Sp1 and YY1 in proximal promoter region in initiation of transcription of the mu opioid receptor gene. J Cell Biochem. 2008, 104: 237-250. 10.1002/jcb.21616.
Liu QR, Lu L, Zhu XG, Gong JP, Shaham Y, Uhl GR: Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Res. 2006, 1067: 1-12. 10.1016/j.brainres.2005.10.004.
McGinty JF, Whitfield TW, Berglind WJ: Brain-derived neurotrophic factor and cocaine addiction. Brain Res. 2010, 1314: 183-193. 10.1016/j.brainres.2009.08.078.
Hall FS, Drgonova J, Goeb M, Uhl GR: Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology. 2003, 28: 1485-1490. 10.1038/sj.npp.1300192.
Kolb JE, Trettel J, Levine ES: BDNF enhancement of postsynaptic NMDA receptors is blocked by ethanol. Synapse. 2005, 55: 52-57. 10.1002/syn.20090.
Shiraishi-Yamaguchi Y, Furuichi T: The Homer family proteins. Genome Biol. 2007, 8: 206-10.1186/gb-2007-8-2-206.
Lutz S, Shankaranarayanan A, Coco C, Ridilla M, Wieland T, Tesmer JJG: Structure of G-alpha-q-p63RhoGEF-RhoA Complex Reveals a Pathway for the Activation of RhoA by GPCRs. Science. 2007, 318: 1923-1927. 10.1126/science.1147554.
Lynch W, Girgenti MJ, Breslin FJ, Newton SS, Taylor JR: Gene profiling the response to repeated cocaine self-administration in dorsal striatum; a focus on circadian genes. Brain Res. 2008, 1213: 166-177. 10.1016/j.brainres.2008.02.106.
Williams MJ, Adinoff B: The role of acetylcholine in cocaine addiction. Neuropsychopharmacology. 2008, 33: 1779-1797. 10.1038/sj.npp.1301585.
Kozak M: Initiation of translation in prokaryotes and eukaryotes. Gene. 1999, 234: 187-208. 10.1016/S0378-1119(99)00210-3.
Li Y, Kolb B, Robinson TE: The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology. 2003, 28: 1082-1085. 10.1038/sj.npp.1300207.
Benavides DR, Quinn JJ, Zhong P, Hawasli AH, DiLeone RJ, Bibb JA: Cdk5 modulates cocaine reward, motivation, and striatal neuron excitability. J Neurosci. 2007, 27: 12967-12976. 10.1523/JNEUROSCI.4061-07.2007.
Liu XY, Chu XP, Mao LM, Wang M, Lan HX, Neve KA, Wang JQ: Modulation of D2R-NR2B interactions in response to cocaine. Neuron. 2006, 52: 897-909. 10.1016/j.neuron.2006.10.011.
Ma YY, Gui CY, Yu P, Lee DY, Han JS, Cui CL: The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats. Exp Neurol. 2006, 200: 343-355. 10.1016/j.expneurol.2006.02.117.
Schumann J, Yaka R: Prolonged withdrawal from repeated noncontingent cocaine exposure increases NMDA receptor expression and ERK activity in the nucleus accumbens. J Neurosci. 2009, 29: 6955-6963. 10.1523/JNEUROSCI.1329-09.2009.
Thanks go to Darlene D'Amato for her help with Western blots and Chris Mazzone for help with mouse husbandry. This work was supported by grant DA-15464 from the National Institute Drug Abuse, National Institutes of Health.
REM and BAE conceived of the study, designed and performed the PCR analyses and westerns, and wrote the original draft of the manuscript. DDK designed and performed animal treatments and westerns. JEM designed and performed all bioinformatic analyses. XMM designed and performed the immunofluorescence studies. All authors participated in study design, read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Mains, R.E., Kiraly, D.D., Eipper-Mains, J.E. et al. Kalrn promoter usage and isoform expression respond to chronic cocaine exposure. BMC Neurosci 12, 20 (2011). https://doi.org/10.1186/1471-2202-12-20
- Nucleus Accumbens
- Dorsal Striatum
- Medium Spiny Neuron
- Chronic Cocaine